Cargando…

Pharmacotherapy for Age-Related Macular Degeneration

Detalles Bibliográficos
Autor principal:	Ahmadieh, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ophthalmic Research Center 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589225/ https://www.ncbi.nlm.nih.gov/pubmed/23479526

Ejemplares similares

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Age-Related Macular Degeneration and Diabetic Retinopathy
por: Ebneter, Andreas, et al.
Publicado: (2022)

Research Advances in Age-Related Macular Degeneration
por: Abdolrahimzadeh, Solmaz
Publicado: (2022)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

Tumor Necrosis Factor Gene Polymorphisms in Advanced Non-exudative Age-related Macular Degeneration
por: Bonyadi, Mohammad Hossein Jabbarpoor, et al.
Publicado: (2015)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Age-Related Macular Degeneration: New Insights in Diagnosis, Treatment, and Prevention
por: Mathis, Thibaud, et al.
Publicado: (2022)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
por: Ahmadieh, Hamid, et al.
Publicado: (2007)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial
por: Piri, Niloofar, et al.
Publicado: (2014)

Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?
por: Haj Najeeb, Bilal, et al.
Publicado: (2022)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Angiogenin in age-related macular degeneration
por: Skeie, Jessica M., et al.
Publicado: (2011)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Age-Related Macular Degeneration and the Aging Brain
por: Whitson, Heather, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!
por: Natarajan, Sundaram
Publicado: (2013)

Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
por: Keenan, Tiarnan D.L.
Publicado: (2021)

LAMELLAR MACULAR HOLES IN THE PRESENCE OF AGE-RELATED MACULAR DEGENERATION
por: Francone, Anibal, et al.
Publicado: (2020)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging: Alabama Study on Early Age-related Macular Degeneration 2 Baseline
por: McGwin, Gerald, et al.
Publicado: (2022)

New developments in age-related macular degeneration
por: da Cruz, Lyndon
Publicado: (2008)

An update on the genetics of age-related macular degeneration
por: Scholl, Hendrik P.N., et al.
Publicado: (2007)

Lipids, Lipoproteins, and Age-Related Macular Degeneration
por: Ebrahimi, Katayoon B., et al.
Publicado: (2011)

Age-related macular degeneration: current treatments
por: Hubschman, Jean Pierre, et al.
Publicado: (2009)

Transcriptome changes in age-related macular degeneration
por: Whitmore, S Scott, et al.
Publicado: (2012)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Mechanism of Inflammation in Age-Related Macular Degeneration
por: Parmeggiani, Francesco, et al.
Publicado: (2012)

Aflibercept for the Treatment of Age-Related Macular Degeneration
por: Trichonas, George, et al.
Publicado: (2013)

Glycolysis in Patients with Age-Related Macular Degeneration
por: Yokosako, Kanako, et al.
Publicado: (2014)

Age-related macular degeneration: choroidal ischaemia?
por: Coleman, D Jackson, et al.
Publicado: (2013)

Fear of falling in age-related macular degeneration
por: van Landingham, Suzanne W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g7rata5ub6a8g9lfns4gq8igqn